BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PTEN
,
T cell differentiation
,
Arthritis
,
Endothelial cell
,
Alcohol
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antibody dependent cell cytotoxicity
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Hypersensitivity
Skin biopsies of plaque psoriasis patients treated with brodalumab or ustekinumab
Etanercept treatment of psoriasis patients
Non-Hodgkins B cell lymphoma cell lines treated with EZH2 inhibitor EPZ-6438
Diffuse large B-cell lymphoma (DLBCL) and PTEN expression
Explore Curated Studies Results
Literature
Most Relevant Literature
Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for ant…
HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced ris…
Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunother…
Evaluation of antibody-dependent cell cytotoxicity using lactate dehydrogenase (LDH) measurement.
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous ca…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Re…
Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refra…
Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma
Subclass of Donor-specific Antibody as a Risk Factor of Antibody Mediated Rejection in Renal Transpl…
A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ